Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

VANI

Vivani Medical Inc

Apr 14 • 04:00PM ET

1.07

+0.02 1.90 %

Healthcare • Biotechnology • USA • NASD

Peers: MDT ABT SYK BSX HOLX ZBH EW ISRG BAX RMD

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.43	Insider Own	62.02%	Shs Outstand	76.43M	Perf Week	0.94%
Market Cap	90.57M	Forward P/E	-	EPS next Y	-0.38	Insider Trans	41.77%	Shs Float	32.15M	Perf Month	-2.73%
Enterprise Value	93.44M	PEG	-	EPS next Q	-0.08	Inst Own	6.52%	Short Float	1.66%	Perf Quarter	-16.41%
Income	-26.61M	P/S	-	EPS this Y	24.42%	Inst Trans	13.75%	Short Ratio	1.66	Perf Half Y	-21.90%
Sales	0.00M	P/B	5.20	EPS next Y	-16.92%	ROA	-64.05%	Short Interest	0.53M	Perf YTD	-13.01%
Book/sh	0.21	P/C	5.58	EPS next 5Y	0.78%	ROE	-159.62%	52W High	1.92 -44.27%	Perf Year	2.88%
Cash/sh	0.19	P/FCF	-	EPS past 3/5Y	-5.50% 27.77%	ROIC	-81.15%	52W Low	0.92 15.96%	Perf 3Y	5.94%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.36% 6.29%	Perf 5Y	-95.67%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	0.28%	Oper. Margin	-	ATR (14)	0.06	Perf 10Y	-99.17%
Dividend Ex-Date	-	Quick Ratio	2.71	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	45.81	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.71	EPS Q/Q	14.42%	SMA20	-1.24%	Beta	2.23	Target Price	3.75
Payout	-	Debt/Eq	1.21	Sales Q/Q	-	SMA50	-8.93%	Rel Volume	0.14	Prev Close	1.05
Employees	42	LT Debt/Eq	1.08	Earnings	Mar 26 AMC	SMA200	-20.03%	Avg Volume	319.90K	Price	1.07
IPO	Nov 19, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.00% -	Trades		Volume	44,576	Change	1.90%

Mar-26-26 04:45PM	Vivani Medical: Q4 Earnings Snapshot (Associated Press Finance) -5.56%
04:16PM	Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update (GlobeNewswire)
Jan-31-26 08:15AM	Insiders Are Still Scooping Up Under Armour and WR Berkley Shares (24/7 Wall St.)
Jan-29-26 07:30AM	Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026 (GlobeNewswire)
Jan-27-26 04:05PM	Vivani Medical, Inc. Announces Closing of Common Stock Offering (GlobeNewswire) +7.97%
08:45AM	Loading…
08:45AM	GameStop CEO Picks Up 1M Shares, and Other Insiders Return to the Buy Window (24/7 Wall St.)
Jan-25-26 11:36PM	Vivani Medical, Inc. Announces Pricing of Common Stock Offering (GlobeNewswire)
Jan-22-26 07:00AM	Vivani Subsidiary Cortigent to Present Orion System's Advanced Brain Implant Technology in Poster Session at NANS 2026 (GlobeNewswire)
Nov-13-25 07:50AM	Vivani Medical: Q3 Earnings Snapshot (Associated Press Finance) -11.44%
07:45AM	Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-28-25 04:05PM	Vivani Medical, Inc. Announces Closing of Common Stock Offering (GlobeNewswire) +5.99%
03:21PM	Insiders Are Buying These 3 Stocks Hand Over Fist (24/7 Wall St.)
Oct-26-25 07:15PM	Vivani Medical, Inc. Announces Pricing of Common Stock Offering (GlobeNewswire)
Oct-22-25 08:30AM	Vivani Medical to Present at the ThinkEquity Conference on October 30, 2025 (GlobeNewswire)
Oct-03-25 08:30AM	Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off (GlobeNewswire) -8.50%
09:15AM	Loading…
Sep-24-25 09:15AM	Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025 (GlobeNewswire)
Sep-17-25 08:30AM	Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders (GlobeNewswire) +19.83%
Sep-04-25 08:30AM	Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management (GlobeNewswire) +18.10%
Aug-27-25 03:19AM	A brewing GLP-1 showdown, from Big Pharma pills to a biotech implant (Pharma Voice)
Aug-20-25 08:30AM	Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025 (GlobeNewswire)
Aug-13-25 04:32PM	Vivani Medical: Q2 Earnings Snapshot (Associated Press Finance)
04:20PM	Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-05-25 08:10AM	Vivani Medical Announces Rapid Advancement of NPM-139, a Novel Semaglutide Implant, Following Positive Weight Loss Data from an Ongoing Preclinical Study of NPM-139 and Promising Results from the LIBERATE-1 Phase 1 Clinical Study of NPM-115 (GlobeNewswire) +7.14%
07:32AM	EXCLUSIVE: Vivani Prioritizes Semaglutide-Based Implant After Promising Preclinical Data (Benzinga)
Jun-11-25 08:00AM	Vivani Medical Appoints Anthony Baldor as Chief Financial Officer (GlobeNewswire)
Jun-10-25 08:30AM	Vivani Medical to Present at the 2025 BIO International Convention (GlobeNewswire)
Jun-02-25 08:38AM	Vivani Stock Gains After Announcing Spin-Off Plans for Cortigent Unit (Zacks)
May-29-25 08:30AM	Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders (GlobeNewswire) +5.26%
May-13-25 04:36PM	Vivani Medical: Q1 Earnings Snapshot (Associated Press Finance)
04:30PM	Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results (GlobeNewswire)
08:30AM	Loading…
May-07-25 08:30AM	Vivani Medical to Present at the American Association of Pharmaceutical Scientists' "Beyond GLP1s: Where the Science will Take Business Next" Virtual Workshop (GlobeNewswire)
Apr-16-25 08:30AM	Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company (GlobeNewswire)
Apr-15-25 08:30AM	Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity (GlobeNewswire)
08:03AM	EXCLUSIVE: Vivani Medical Collaborates With Okava To Expand Development Of GLP-1 Therapy For Dogs (Benzinga)
Mar-31-25 07:50AM	Vivani Medical: Q4 Earnings Snapshot (Associated Press Finance) -5.41%
07:30AM	Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-27-25 07:32AM	Vivani Medical Announces $8.25M Private Placement Equity Financing (GlobeNewswire)
Mar-26-25 02:51PM	Vivani Medical Gives Data for Weight Loss Implant (Exec Edge)
07:30AM	Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing (GlobeNewswire)
07:00AM	EXCLUSIVE: Vivani Medical Subdermal Semaglutide Implant Shows 20% Weight Loss In Animal Study, With Potential For Once-Yearly Dosing (Benzinga)
07:00AM	Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now (GlobeNewswire)
Mar-25-25 07:00AM	Presenting on the Emerging Growth Conference 80, Day 1 on March 26 - Register Now (GlobeNewswire)
Mar-24-25 08:30AM	Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025 (Business Wire)
Mar-17-25 12:00PM	What Makes Vivani Medical (VANI) a New Buy Stock (Zacks)
Mar-13-25 04:06PM	Vivani Medical Achieves 1st Implant & Full Enrollment in Overweight Trial (Exec Edge)
01:00PM	Vivani treats first patient with long-lasting drug implant for weight loss (Medical Device Network)
07:30AM	Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults (Business Wire)
07:00AM	EXCLUSIVE: Vivani Medical Announces First Implant In Early-Stage Human Study Of GLP-1 Implant For Obesity (Benzinga)
12:49AM	Vivani to spin off neurostimulation business (MedTech Dive)
Mar-12-25 04:51PM	Vivani Medical to Spin-Off Neurostimulation Division Cortigent for Nasdaq Listing (Exec Edge)
01:49PM	Vivani Medical to spin-off neurostim business Cortigent as public company (Medical Device Network)
08:30AM	Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business (Business Wire)
08:00AM	EXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder Value (Benzinga)
Jan-15-25 07:00AM	Presenting on the Emerging Growth Conference 78 Day 2 on January 16 Register Now (GlobeNewswire)
Jan-14-25 07:00AM	Presenting on the Emerging Growth Conference 78 Day 1 on January 15 Register Now (GlobeNewswire)
Dec-20-24 05:11AM	Vivani begins exenatide implant trial for obesity in Australia (Medical Device Network)
Dec-19-24 08:30AM	Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia (Business Wire)
08:00AM	EXCLUSIVE: Vivani Medical Initiates First Human Clinical Trial With GLP-1 Implant For Weight Loss In Australia (Benzinga)
Dec-04-24 08:30AM	Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast (Business Wire) -5.67%
Nov-13-24 08:35AM	Vivani Medical: Q3 Earnings Snapshot (Associated Press Finance) +11.20%
08:30AM	Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results (Business Wire)
Oct-30-24 07:00AM	Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now (GlobeNewswire)
Oct-29-24 07:00AM	Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now (GlobeNewswire)
Oct-22-24 08:30AM	Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024 (Business Wire)
Sep-27-24 06:12AM	Vivani Medical obtains Australian approval to begin GLP-1 implant trial (Medical Device Network)
Sep-26-24 12:00PM	Vivani Medical to Test Implant in Obese and Overweight Patients (Exec Edge)
08:30AM	Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia (Business Wire)
08:00AM	EXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in Australia (Benzinga)
Sep-25-24 07:00AM	Presenting on the Emerging Growth Conference 75 Day 2 on September 26 (GlobeNewswire)
Sep-24-24 07:00AM	Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now (GlobeNewswire)
Sep-23-24 08:57AM	Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024 (Business Wire)
Sep-04-24 08:00AM	Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant (Business Wire)
07:33AM	EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity (Benzinga)
Aug-28-24 07:10PM	Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference (Business Wire)
Aug-13-24 04:25PM	Vivani Medical: Q2 Earnings Snapshot (Associated Press Finance) +8.62%
04:05PM	Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results (Business Wire)
Jul-12-24 06:52AM	Vivani to start in-human trial for GLP-1 implant for treating obesity (Medical Device Network)
Jul-11-24 08:00AM	Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115 (Business Wire) +5.60%
07:29AM	EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year (Benzinga)
Jun-13-24 12:58PM	Vivani Medical Receives FDA Clearance for Trial of Type-2 Diabetes Mini-Implant (Exec Edge)
08:25AM	EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's IND Gains FDA Clearance For Clinical Use (UPDATED) (Benzinga)
08:00AM	Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant (Business Wire)
May-28-24 09:30AM	EXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Veterinary Use (Benzinga)
08:00AM	Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant (Business Wire)
May-13-24 08:52PM	VANI Stock Earnings: Vivani Medical Meets EPS for Q1 2024 (InvestorPlace)
04:55PM	Vivani Medical: Q1 Earnings Snapshot (Associated Press Finance)
04:45PM	Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results (Business Wire)
May-09-24 08:00AM	Vivani Medical to Present at TIDES Conference 2024 (Business Wire)
Mar-26-24 09:02PM	Vivani Medical Inc (VANI) Reports Fourth Quarter and Full Year 2023 Financial Results (GuruFocus.com)
01:52PM	VANI Stock Earnings: Vivani Medical Beats EPS for Q4 2023 (InvestorPlace)
08:38AM	Vivani Medical: Q4 Earnings Snapshot (Associated Press Finance)
08:30AM	Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Mar-06-24 08:00AM	Vivani Medical Appoints Daniel Bradbury to its Board of Directors (Business Wire)
Mar-01-24 07:49AM	Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants (Business Wire) -26.78%
Feb-28-24 01:59PM	Why Is Vivani Medical (VANI) Stock Up 300% Today? (InvestorPlace) +270.30%
08:30AM	Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic/Wegovy and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio (Business Wire)
Nov-14-23 06:10AM	Vivani Medical: Q3 Earnings Snapshot (Associated Press Finance) -6.27%
06:00AM	Vivani Medical Provides Business Update and Reports Third Quarter Financial Results (Business Wire)
Oct-16-23 06:00AM	Vivani Medical to Present at BIO Investor Forum (Business Wire)
Sep-13-23 09:25PM	Director Gregg Williams Acquires 13,997 Shares of Vivani Medical Inc (VANI) (GuruFocus.com)

Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. It operates under the Biopharm Division and Neuromodulation Division segments. The company was founded by Adam Mendelsohn on May 22, 2003 and is headquartered in Alameda, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Williams Gregg	Director	Mar 15 '26	Buy	1.07	1,575,231	1,683,335	31,357,183	Mar 16 06:15 AM
Williams Gregg	Director	Feb 15 '26	Buy	1.06	1,866,492	1,983,333	29,781,952	Feb 17 06:01 AM
Williams Gregg	Director	Jan 27 '26	Buy	1.48	1,351,351	1,999,999	27,915,460	Jan 28 10:01 AM
Williams Gregg	Director	Jan 15 '26	Buy	1.14	1,737,765	1,983,334	26,564,109	Jan 20 09:00 AM
Mendelsohn Aaron	Director	Dec 29 '25	Buy	1.23	20,000	24,600	188,170	Dec 31 09:00 AM
Williams Gregg	Director	Dec 15 '25	Buy	1.14	1,737,765	1,983,334	24,826,344	Dec 16 09:00 AM
Williams Gregg	Director	Nov 15 '25	Buy	1.14	1,737,764	1,983,333	23,088,579	Nov 17 09:00 AM
Williams Gregg	Director	Oct 27 '25	Buy	1.62	3,703,703	5,999,999	21,350,815	Oct 28 09:00 AM
Williams Gregg	Director	Oct 15 '25	Buy	1.14	1,737,764	1,983,333	17,647,112	Oct 16 09:13 AM
Williams Gregg	Director	Sep 15 '25	Buy	1.16	2,068,453	2,400,001	15,909,348	Sep 17 09:48 AM
Williams Gregg	Director	May 15 '25	Buy	1.01	6,836	6,904	13,838,490	May 16 08:11 PM
Williams Gregg	Director	May 14 '25	Buy	1.01	3,499	3,534	13,831,654	May 16 08:11 PM
Williams Gregg	Director	May 16 '25	Buy	1.01	2,405	2,429	13,840,895	May 16 08:11 PM
Williams Gregg	Director	Apr 24 '25	Buy	1.01	1,113	1,124	13,828,155	Apr 28 07:59 PM
Williams Gregg	Director	Apr 21 '25	Buy	1.01	1,569	1,585	13,826,799	Apr 23 08:41 PM
Williams Gregg	Director	Apr 22 '25	Buy	1.01	243	245	13,827,042	Apr 23 08:41 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VANI

Vivani Medical Inc

Upgrade your Finviz experience